Astrovirus replicon methods and compositions
By designing recombinant astroviral replicons and using nanostructured lipid vectors to deliver, the problems of genome size and toxicity risks in the prior art are solved, and efficient immune response induction and vaccine development are achieved.
Patent Information
- Application Number
- CN202080041231.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-10
- Filing Date
- 2020-06-10
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-06-10
AI Technical Summary
The existing replicon technology mainly relies on larger viruses as vectors, limiting the size and type of genomes, making it difficult to develop replicons of smaller genomes that are the same or similar to the alpha virus replicon, which affects the efficiency and safety of vaccine development. .
A recombinant astroviral replicon was designed to contain coding sequences for the non-structural proteins of the astroviral NP1a and NP1b, and delivered through nanostructured lipid vectors, achieving induction of immune responses, reducing genome size and potential toxicity risk.
The same immune response effect as the alpha virus replicon is achieved, while reducing genome size and toxicity risks, simplifying the process of nucleic acid manipulation and vaccine development.
Smart Images

Figure BDA0003389730050000121 
Figure BDA0003389730050000131 
Figure BDA0003389730050000141
Abstract
Description
Technical Field
[0001] The present invention relates to recombinant replicons for eliciting improved immune responses and methods of using the same. Background Art
[0002] A fundamental aspect of using vaccines to generate immunity is to deliver an immunogenic agent to a subject in order to elicit a response from the subject's immune system. Specifically, effective stimulation of the subject's adaptive immune system is important in developing long-term immunity to specific pathogens. One approach to immunization against viral pathogens involves the introduction of independently replicable viral genetic material, i.e., replicons, into host cells, thereby causing the expression and secretion of antigenic proteins that stimulate the immune system.
[0003] Current replicon technology was originally conceptualized and developed based on the ability to package RNA replicons in virus-derived nucleocapsids with or without envelope glycoproteins, known as viral replicon particles (VRPs). This approach is necessarily limited to larger viruses with sufficient packaging capacity that would allow the incorporation of large amounts of exogenous genomic information. To meet this requirement, two commonly used VRPs are derived from alphaviruses or flaviviruses, both of which have relatively large genomes (>11 kilobases) and particle sizes (>60 nm).
[0004] The emergence of non-viral delivery of RNA using various formulations that can prevent RNA degradation makes it possible to develop naked RNA replicons using positive-strand RNA viruses containing infectious RNA genomes. There is no need to package the replicons in viral particles, and there is no need to use replicons derived from larger viruses. However, this technology is still focused on the use of alpha virus and flavivirus replicons, which is likely due to the extensive use of the two viral replicons in history. In addition, naked RNA replicons based on alpha viruses have been proven to be effective as vaccine platforms because they have robust antigen expression kinetics, which are attributed to the use of subgenomes encoding heterologous genes of interest and robust induction of the host's IFN-mediated antiviral state and resistance to the host's IFN-mediated antiviral state. However, since it is desirable to reduce the effective dose of replicon material in order to best avoid potential toxicity problems, genome size remains a consideration. In addition, when smaller constructs are used, nucleic acid manipulation using recombinant DNA technology is greatly simplified, resulting in greater gene tractability and faster candidate vaccine development. Therefore, the development of replicons with smaller genomes that exhibit the same or similar beneficial properties as existing platforms remains a desirable goal.
[0005] The present disclosure overcomes shortcomings in the art by providing recombinant Astrovirus replicons that meet this desirable profile and are effective in inducing an increased immune response. Summary of the invention
[0006] According to the description, each embodiment includes a recombinant replicon nucleic acid, the recombinant replicon nucleic acid comprising: a first open reading frame, the first open reading frame comprising a.) a subgenomic nucleic acid sequence encoding a protein of interest that can be secreted by a cell; b.) a second open reading frame, the second open reading frame comprising a nucleic acid sequence encoding a first astrovirus nonstructural protein (nsP1a) and comprising a hypervariable region; and c.) a third open reading frame, the third open reading frame comprising a nucleic acid sequence encoding a second astrovirus nonstructural protein (nsP1b) and comprising a subgenomic promoter, the subgenomic promoter being positioned to facilitate initiating transcription of the subgenomic nucleic acid sequence. In some embodiments, the recombinant replicon nucleic acid has the following structure: c.→b.→a. In some embodiments, the recombinant replicon nucleic acid has a 7-methylguanylate cap at its 5' end.
[0007] In some embodiments, the first open reading frame further comprises a subset of nucleic acid sequences encoding an Astrovirus structural protein (VP90). In specific embodiments, the subset consists of 5 to 50 nucleotides. In other specific embodiments, the subset consists of 30 nucleotides.
[0008] In some embodiments, the recombinant replicon nucleic acid further comprises an Astrovirus conserved sequence element that begins within the first open reading frame and extends beyond the 3' end of the first open reading frame.
[0009] In some embodiments, the Astrovirus genotype of the hypervariable region is different from the Astrovirus genotype of the recombinant replicon nucleic acid. In some of these embodiments, the Astrovirus genotype of the recombinant replicon nucleic acid is HAstV VII, and the Astrovirus genotype of the hypervariable region is HAstV IV.
[0010] In some embodiments, the third open reading frame comprises a translation upstream ribosome binding site.
[0011] In some embodiments, the first open reading frame further comprises a nucleic acid sequence encoding a peptide having ribosome skipping properties. In a specific embodiment, the peptide is a 2A peptide (T2A) from the capsid protein of Thosea asigna virus.
[0012] Other embodiments include a nanoparticle comprising any of the above-mentioned recombinant replicon nucleic acids. In some of these embodiments, the nanoparticle consists essentially of a nanostructured lipid carrier containing the recombinant replicon nucleic acid. Other embodiments include a formulation comprising a plurality of the nanoparticles in a pharmaceutically acceptable carrier.
[0013] In some embodiments, a method of treating a subject to immunize the subject comprises administering the above formulation to the subject and thereby eliciting an immune response in the subject. In some of these embodiments, the immune response comprises CD4+ T cell activation.
[0014] In some embodiments, a composition includes any of the above-described recombinant replicon nucleic acids in a pharmaceutically acceptable carrier.
[0015] In some embodiments, an isolated cell comprises any of the above-described recombinant replicon nucleic acids. In other embodiments, a method of delivering a therapeutic amount of a protein of interest to a subject comprises administering to a subject an effective amount of the isolated cell, wherein the protein of interest is a therapeutic protein, and the cell secretes the protein of interest and thereby delivers a therapeutic amount of the protein of interest to the subject.
[0016] In some embodiments, a method of secreting a protein of interest from a cell comprises introducing any of the above-described recombinant replicon nucleic acids into the cell under conditions whereby the protein of interest is secreted, and wherein the cell is in cell culture, whereby the protein is secreted from the cell. Some embodiments further comprise the step of harvesting the protein of interest from the cell culture. Another embodiment comprises a composition comprising the protein of interest produced by this method. In still other embodiments, a method of delivering a therapeutic protein of interest to a subject comprises administering the composition to the subject. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1A -C shows the organization of the human Astrovirus genome and the importance of this organization for the expression of proteins of interest. Figure 1A A schematic diagram of the genome organization of human Astrovirus (HAstV) comprising three open reading frames (ORFs), ORF 1a, ORF 1b and ORF 2, is shown, and the positions of highly conserved sequence elements flanking ORF 2 that are proposed to play a role in subgenomic transcription and translation are also shown. Figure 1BA table depicting four HAstV replicons is shown. Luciferase (nLUC) is encoded and each has one of four combinations of modifications to the flanking sequences derived from HAstV ORF2 and the 3' untranslated region (3'UTR) adjacent to ORF2. Figure 1C Shown by Figure 1B Expression of nLUC by the replicons described in 293T cells transfected with 100 ng of the replicon and alphavirus replicons encoding nLUC or Zika virus (ZIKV) antigens as positive and negative controls, respectively, and harvested 24 hours later.
[0018] Figure 2A -G shows a comparison between nanostructured lipid formulated replicons in their ability to induce an immune response in C57B1 / 6 mice injected intramuscularly. Figure 2A Shown is a schematic diagram of an alphavirus-derived replicon featuring a subgenome encoding a gene of interest (GOI). Figure 2B Shown are the results of plaque reduction neutralization assays performed on alphavirus replicons carrying the ZIKV gene (four doses of NLC formulated replicons) as well as naked replicon controls and mock injected controls. Figure 2C Shown are the percentages of two different antigen-specific CD8 T cells induced by alphavirus replicons. Figure 2D Shown are the levels of two different antigen-specific CD4 T cells induced by alphavirus replicons. Figure 2E Shown from Figure 1B Schematic representation of one of the astroviral replicons (5'-HAstV-3') having a subgenome encoding a GOI. Figure 2F Shown are the combined percentages of antigen-specific CD4 T cells induced by alphavirus replicons and astrovirus replicons encoding two GOIs: ZIKV NS3 antigen and Mycobacterium tuberculosis antigen ID- 93. Also shown are the results from ID-93 protein alone and in the presence of GLA-SE adjuvant. Figure 2G Shown are anti-hemagglutinin immunoglobulin G ELISA titers after a single dose of an unadjuvanted linear epitope (PR8 hemagglutinin (HA) subunit) given to naive mice and mice previously primed with an astrovirus replicon encoding a partial sequence of the hemagglutinin gene.
[0019] Figure 3A -D shows the effect of ORF 2 sequence length on the predicted replicon secondary RNA structure and gene expression. Figure 3AThe predicted secondary structure of a 400 nucleotide (nt) region encompassing the 3' end of ORF 1b and the 5' end of ORF 2 of wild-type (WT) HAstV is shown. The triple hairpin structure is depicted with light and medium lines, with the ORF 2 start codon boxed. Figure 3B Shown is the predicted secondary structure of a 167-nt region in the 5′-3′ HAstV replicon encompassing the first 9 nt of ORF 2, depicting a clear loss of the triple hairpin structure. Figure 3C The predicted secondary structure of the 188-nt region encompassing the first 30 nt of ORF 2 (depicted as a light line at the lower right of the structure) is shown, in which the triple hairpin structure is apparently stabilized. Figure 3D The results for the first 9 nt of ORF 2 in the replicon are shown. Figure 1B Results of luciferase assays in 293T cells with three replicons of and three replicons containing the first 30 nt of ORF 2 with the following: unmodified flanking sequence (5'-30nt-3'); modified 5' flanking sequence (Δ5'-30nt-3'); and unmodified flanking sequence with the addition of the ribosomal skipping sequence of the 2A (T2A) ribosomal skipping sequence of the cleaved thrush virus (5'-30nt-T2A-3').
[0020] Figure 4A -C shows the results of a coupled transcription and translation assay for detecting subgenomic transcription and translation in alphavirus and astrovirus replicons. Figure 4A Subgenomic transcription in CaCo-2 cells infected with wild-type HAstV is shown. Figure 4B Shown are the results of quantitative reverse transcription polymerase chain reaction (qRT-PCR) and luciferase assays following transfection of 293T cells with the 5'-30nt-T2A-3' replicon encoding nLUC and an uncapped control. Figure 4C Shown are the results of qRT-PCR and luciferase assays following transfection of 293T cells with alphavirus replicons encoding nLUC and uncapped controls.
[0021] Figure 5 Shown is a comparison of gene expression in two cell types between 5'-30nt-T2A-3' replicons in which the hypervariable region (HVR) of ORF 1a belongs to the native genotype (HVR-VII) or the divergent genotype (HVR-IV).
[0022] Fig. 6A -B shows the results of a bicistronic reporter assay used to study the ORF 2 translation control mechanism, in particular translation termination-reinitiation. Fig. 6A A summary of selected mutations of ORF 1b is shown. Figure 6BThe results show that 100ng Fig. 6A Results of dual luciferase assays performed on BHK cell lysates 24 h after transfection with each plasmid as described in .
[0023] Fig. 7A -B shows the dependence of downstream ORF expression on the upstream ORF sequence. Fig. 7A A depiction of a plasmid construct with a deletion in ORF 1b is shown. Figure 7B Shown are the results of dual luciferase assays performed in BHK cells 24 hours after transfection with 100 ng of each plasmid. DETAILED DESCRIPTION
[0024] As used herein, "replicon nucleic acid" or "replicon" refers to a region of a ribonucleic acid (RNA) molecule or RNA that replicates from a single replication origin. The term "replicon nucleic acid" refers to a replicon nucleic acid that has been altered by human intervention. As a non-limiting example, a recombinant nucleic acid molecule: 1) has been synthesized or modified in vitro, such as using chemical or enzymatic techniques (e.g., by using chemical nucleic acid synthesis or by using enzymes for replication, polymerization, exonucleoside, endonucleoside, connection, reverse transcription, transcription, base modification (including, for example, methylation) or recombination (including homology and site-specific recombination) of nucleic acid molecules); 2) contains essentially unconnected connecting nucleotide sequences; 3) has been engineered using molecular cloning techniques so that it lacks one or more nucleotides relative to a naturally occurring nucleic acid molecule sequence; and / or 4) has been manipulated using molecular cloning techniques so that it has one or more sequence changes or rearrangements relative to a naturally occurring nucleic acid sequence.
[0025] The term "nucleic acid sequence" refers to the sequence of a nucleic acid molecule. The nucleotide base nomenclature as set forth in 37C.FR § 1.822 is used herein. Nucleic acid molecules can be any length, including but not limited to between 3Kb and 50Kb, such as between 3Kb and 40Kb, between 3Kb and 40Kb, between 3Kb and 30Kb, between 3Kb and 20Kb, between 5Kb and 40Kb, between 5Kb and 40Kb, between 5Kb and 30Kb, between 5Kb and 20Kb, or between 10Kb and 50Kb, such as between 15Kb and 30Kb, between 20Kb and 50Kb, between 20Kb and 40Kb, between 5Kb and 25Kb, or between 30Kb and 50Kb. Nucleic acid molecules can also be, for example, more than 50kb.
[0026] The term "open reading frame" (ORF) means a nucleic acid sequence consisting of a continuous stretch of codons starting with a start codon (usually AUG) and ending with a stop codon (usually UAA, UAG or UGA). More than one open reading frame can exist in a single nucleic acid molecule, and an open reading frame can overlap with another open reading frame on the same molecule. For example, the nucleic acid sequence of one open reading frame can contain the start codon of another open reading frame.
[0027] The term "Astroviral 5' untranslated region (5'UTR)" means a fragment of the Astroviral genome comprising a nucleic acid sequence located upstream of the start AUG of the open reading frame ORF 1a.
[0028] By "Astroviral 3' untranslated region (3'UTR)" is meant a fragment of the Astroviral genome comprising the nucleic acid sequence located downstream of the stop codon of the open reading frame ORF2.
[0029] A "subgenomic promoter" is a promoter that directs transcription of a subgenomic messenger RNA as part of the replication process. Such a promoter may have a wild-type sequence or a sequence that has been modified from the wild-type sequence but retains promoter activity.
[0030] The term "conserved sequence element (CSE)" describes an RNA element with similar position, sequence and secondary structure in the genomes of all known human astroviruses.
[0031] As used herein, an "isolated cell" is a cell or cell population that has been removed from the environment in which the cell naturally exists and / or has been altered or modified from the state in which the cell exists in its natural environment. An isolated cell can be, for example, a cell in cell culture. An isolated cell can also be a cell that can be in an animal and / or introduced into an animal, and wherein the cell has been altered or modified, for example, by introducing an alpha virus particle into the cell.
[0032] "Subject" includes, but is not limited to, warm-blooded animals such as humans, non-human primates, horses, cows, cats, dogs, pigs, rats, and mice.
[0033] Some embodiments provide compositions (e.g., pharmaceutical compositions) comprising a replicon encapsulated in a supramolecular structure to form a nanoparticle, wherein a plurality of such nanoparticles are dispersed in a pharmaceutically acceptable carrier. In particular embodiments, the nanoparticles include a replicon encapsulated in a lipid-based nanoparticle. In a specific aspect, the nanoparticles include a replicon encapsulated in a nanostructured lipid carrier (NLC). An example of a suitable NLC is described in Erasmus et al., Molecular Therapeutics 26(10):2507-2522 (2018).
[0034] "Pharmaceutically acceptable" means a material that is not biologically or otherwise undesirable, i.e., the material can be administered to a subject with the selected nanoparticles without causing a substantial deleterious biological effect or interacting in a deleterious manner with any of the other components of a composition comprising the other components. Pharmaceutically acceptable carriers are suitable for administration or delivery to humans and other subjects. As is well known to those skilled in the art, the carrier will naturally be selected to minimize any degradation of the active ingredient and to minimize any adverse side effects in the subject (see, e.g., Remington's Pharmaceutical Science; latest edition). Pharmaceutical formulations such as vaccines or other immunogenic compositions may include an immunogenic amount of the disclosed Astrovirus replicons and a pharmaceutically acceptable carrier. Exemplary pharmaceutically acceptable carriers include, but are not limited to, sterile pyrogen-free water and sterile pyrogen-free saline solutions.
[0035] The administration of various compositions (e.g., nucleic acids, nanoparticles, pharmaceutical compositions) can be accomplished by any of several different approaches. The compositions can be administered intramuscularly, subcutaneously, intraperitoneally, intradermally, intranasally, intracranially, sublingually, intravaginally, intrarectally, orally or topically. The compositions can also be administered transdermally by skin scarification or by a patch or liquid. The compositions can also be delivered subcutaneously in the form of a biodegradable material that releases the compositions over a period of time. The compositions can also be delivered intramuscularly by injection.
[0036] Nucleic acids, nanoparticles and pharmaceutical compositions can be used in methods for delivering secreted proteins of interest to cells, which can be cells in a subject. Therefore, some embodiments provide a method for introducing an effective amount of the nucleic acid, nanoparticle and / or composition of the embodiments into a cell. A method for delivering an effective amount of the nucleic acid, nanoparticle and / or composition of the embodiments to a subject is also provided. According to well-known gene therapy protocols, such methods can be used to confer a therapeutic effect on cells and / or subjects.
[0037] Astrovirus replicons offer an attractive alternative by combining their smaller genome size with those features offered by alphavirus replicons: a subgenomic RNA replication strategy and a delayed but robust IFN induction. The astrovirus replicon machinery is encoded by approximately 4 kb RNA, whereas those of alphavirus or flavivirus origin are encoded by approximately 8 kb RNA. This reduces the effective dose in terms of copy number by approximately 2-fold.
[0038] As used herein, "effective amount" refers to the amount of a composition or formulation sufficient to produce a desired effect, which may be a therapeutic effect. The effective amount will vary with the age of the subject, the general condition; the severity of the condition being treated; the specific agent being administered; the duration of treatment; the nature of any concurrent treatment; the pharmaceutically acceptable carrier used; and similar factors within the knowledge and expertise of those skilled in the art. Appropriately, the effective amount in any individual case can be determined by those skilled in the art by reference to relevant texts and literature and / or by using routine experiments. (See, for example, Remington, The Science and Practice of Pharmacy (20th ed. 2000)).
[0039] The replicon RNA compositions described herein are administered in a manner compatible with dosage formulations and in an amount that is prophylactically and / or therapeutically effective. 4 to 10 10 In the range of unit doses (e.g., 10 4 , 10 5 , 10 6 , 10 7 , 10 8 , 10 9 or 10 10 The amount of the active ingredient to be administered depends on: the subject to be treated, the route of administration or delivery of the particles, the immunogenicity of the expressed product, the type of effector immune response desired, and the degree of protection desired. The effective amount of the active ingredient required to be administered or delivered may depend on the judgment of a physician, veterinarian or other health practitioner and may be specific to a given subject, but such determination is within the skill of such practitioners.
[0040] The disclosed compositions and formulations can be administered in a single dose regimen or a multiple dose regimen. A multiple dose regimen is a regimen in which the main course of administration may comprise 1 to 10 or more individual doses, followed by other doses administered at subsequent time intervals as needed to maintain and / or enhance the desired effect (e.g., therapeutic response).
[0041] The term "therapeutic amount" refers to an amount sufficient to confer a modulating effect (e.g., a therapeutic response) on a subject suffering from a condition, disease, or disorder, which modulating effect, for example, can be a beneficial effect, including an improvement in the subject's condition (e.g., an improvement in one or more symptoms), a delay or slowing of the progression of a condition, a delay in the onset of a condition, disease, or disorder, and / or a change in any of the clinical parameters of the condition, disease, or disorder, etc., as are well known in the art. Another example of a therapeutic response contemplated in the present disclosure is increasing resistance to pathogenic disease by stimulating the subject's immune system.
[0042] As used herein, "a", "an", and "the" may mean one or more than one, depending on the context in which they are used. For example, "a" cell may mean one cell or a plurality of cells. Furthermore, as used herein, "and / or" refers to and encompasses any and all possible combinations of one or more of the associated listed items, as well as the lack of a combination when interpreted in an alternative form ("or").
[0043] It should be understood that the foregoing detailed description is given by way of illustration only and that modifications and variations may be made therein without departing from the spirit and scope of the present invention.
[0044] Examples
[0045] The following examples are provided to illustrate certain disclosed embodiments and should not be construed as limiting the scope of the disclosure in any way.
[0046] Example 1 - Materials and Methods
[0047] Preparation of replicon RNA
[0048] Various astrovirus replicon sequences were synthesized and cloned into plasmids downstream of the T7 promoter and upstream of the hepatitis delta virus ribozyme sequence, T7 terminator, and NotI restriction site. To prepare RNA for downstream studies, the purified plasmids were linearized by restriction digestion with NotI enzyme and then purified by phenol-chloroform and ethanol precipitation. The linearized template was then used for RNA transcription using T7 polymerase and purified by LiCl precipitation and ethanol wash. The RNA transcripts were then capped using vaccinia virus capping enzyme and purified by LiCl precipitation and ethanol wash.
[0049] Example 2 - Protein expression from replicons with selected modifications
[0050] The wild-type (WT) human astrovirus (HAstV) replication machinery consists of 5' and 3' untranslated regions (UTRs) and the nonstructural proteins nsP1a and nsP1b, encoded by two overlapping open reading frames, ORF 1a and ORF 1b, respectively, which are processed by the ribosomal frameshift machinery. The 3' end of ORF 1b contains a proposed subgenomic promoter that is assumed to initiate transcription of subgenomic RNAs mediated by proteins translated from ORFs 1a and 1b. The structural proteins encoded by ORF 2 are thought to be translated from this subgenomic RNA, whose start codon overlaps with the 3' end of ORF 1b. In addition, there is a highly conserved stem-loop sequence that begins at the 3' end of ORF 2 and ends in the 3'UTR. See Figure 1A .
[0051] Four replicons containing combinations of these conserved sequence elements were developed to test whether the four replicons were important for ORF2 expression. The 5'-3' replicon contained intact 5' and 3' conserved sequence elements. The other replicons contained synonymous mutations in ORF 1b that silenced the start methionine of ORF 2, (Δ5'), deletions of the conserved 3' ORF 2 sequence (Δ3'), or both (Δ5'-Δ3'). ORF 2 contained a luciferase (nLUC). Figure 1B .
[0052] To test the effect of sequence elements on ORF 2 expression, 293T cells were transfected with 100 ng of each replicon and alphavirus replicons encoding nLUC or Zika virus (ZIKV) antigens as positive and negative controls, respectively, and nLUC expression was measured 24 hours later. Figure 1C The results of this test are shown in . Although the intact 5' and 3' sequences enhanced nLUC expression 5-fold compared to the Δ5'-Δ3' counterpart and about 25-fold compared to background, the expression level was about 17,000-fold lower than the alphavirus positive control, suggesting that additional nucleic acid sequences may be important for enhancing ORF 2 expression.
[0053] Example 3 - CD4+ T cell induction by recombinant astrovirus replicons
[0054] Next, the ability of the 5'-3' HAstV replicons to induce T cell responses to the Mycobacterium tuberculosis antigen ID-93 or the Zika virus NS3 antigen was evaluated. To prepare these constructs, sequences encoding the ID-93 or Zika virus NS3 proteins were synthesized and cloned into the 5'-3' HAstV replicon ( between the AvrII restriction site and the PvuI restriction site) using Gibson assembly. Figure 2E ) and an alphavirus replicon derived from the Venezuelan equine encephalitis virus TC-83 strain between the PflMI restriction site and the SacII restriction site ( Figure 2A ). Capped RNA was then prepared as described in Example 1 above and transfected into BHK cells to confirm antigen expression by Western blot (data not shown). After confirming antigen expression, the replicons were formulated in nanostructured lipid carriers and 1 μg of each replicon was administered to C57BL / 6 mice by a single intramuscular injection. For the ID-93 replicon, additional controls for the protein subunits alone and with adjuvant (GLA-SE) were included to compare T cell responses between the replicons and a more traditional vaccine preparation, which has previously been shown to induce potent antigen-specific CD4 + T cell responses. Fourteen days after a single injection, spleens were harvested and stimulated with MHC-II restricted peptides derived from Zika virus NS3 or mycobacterium ID-93 antigens and stained for analysis by flow cytometry ( Figure 2F ).
[0055] The results shown in FIG. 2 demonstrate that although non-viral delivery of alphavirus-derived replicons encoding bacterial or viral antigens drives potent CD8+ and antibody responses to the encoded antigens after a single intramuscular injection ( Figure 2B -D), but astrovirus-derived replicons encoding the same antigen drove significantly higher antigen-specific CD4+ T cell responses ( Figure 2F ).
[0056] To test whether these CD4+ T cell responses to linear epitopes could enhance antibody responses to the entire protein subunit, C57Bl / 6 mice were primed with a single dose of an astrovirus replicon encoding a 15 amino acid (aa) sequence of the hemagglutinin (HA) gene, which is conserved among seasonal influenza virus subtypes and previously shown to be reactive in C57Bl / 6 mice. Twenty-one days later, a single dose of unadjuvanted recombinant PR8 HA subunit protein was administered to astrovirus RNA primed mice as well as naive mice, and anti-HA IgG ELISA titers were compared. The anti-HA ELISA titers of mice primed with astrovirus RNA encoding the conserved 15aa sequence (mean = 1:2200) were significantly higher (5.5-fold) than those of mice receiving protein alone (mean = 1:400). Figure 2G ).
[0057] Example 4 - Effect of ORF 2 sequence composition on expression and translation
[0058] A. ORF 2 sequence length
[0059] The predicted secondary RNA structure of the 400-bp region of WT HAstV containing the proposed subgenomic RNA promoter was evaluated and compared with the predicted structure of the 5'-3' nLUC replicon containing the first 9 nucleotides (nt) of ORF 2 of Examples 2 and 3. Figure 3A In the figure, a triple hairpin structure can be clearly observed (shown as a structure presented with light and medium lines), where the start codon of ORF 2 is boxed. The predicted secondary structure of the 5'-3' replicon with the first 9 nt of ORF 2 ( Figure 3B In the figure (shown in Figure 2), there are no two hairpin structures, only hairpins that are conserved between the WT sequence and the replicon sequence (depicted in light lines). By including an additional 21 nt from ORF 2 (depicted in light lines at the bottom right of the figure), the three-hairpin structure appears to be stabilized in the prediction ( Figure 3C ).
[0060] To evaluate the role of these 30 nt in HAstV replication, additional HAstV replicons containing the 30-nt sequence with or without synonymous mutations in ORF 1b were constructed (5'-30nt-3' replicons or Δ5'-30nt-3' replicons, respectively). For the 5'-30nt-3' replicon encoding the N-terminal 10 amino acids of ORF 2, the ribosomal skipping sequence of the 2A (T2A) ribosomal skipping sequence of the lycopodiella virus was inserted before the nLUC gene to prepare the 5'-30nt-T2A-3' replicon.
[0061] After in vitro transcription and blocking of RNA, 293T cells were transfected with the same dose of each construct, each of which contained two Venezuelan equine encephalitis virus replicons (one Venezuelan equine encephalitis virus replicon (VEE-nLUC) containing the nLUC gene and another Venezuelan equine encephalitis virus replicon (VEE-ZIKV) containing the ZIKV antigen gene as positive and negative controls, respectively. 24 hours after transfection, luciferase assays were performed to quantify heterologous gene expression. Figure 3D The results shown in support the conclusion that the 30 nt enhances heterologous gene expression and that the ORF 2 start codon is involved in efficient translation initiation, with the detected luciferase activity being more than 16,000-fold above background levels, approaching within 30-fold of alphavirus replicating viral RNA.
[0062] B. Effects of identified ORF 2 sequences on translation
[0063] Having demonstrated the importance of the first 30 nt in ORF 2 expression, we next sought to determine the role of this sequence element in subgenomic transcription.
[0064] The quantitative reverse transcription (qRT) PCR assay was designed to quantify the genomic and subgenomic copies accumulated during astrovirus replication and to validate the assay in the context of WT astrovirus replication. CaCo-2 cells were infected with WT astrovirus at a multiplicity of infection of 0.1 and cell lysates were collected at 0, 4, 8, 12 and 24 hours post infection. RNA was then extracted and run in a qRT-PCR assay together with T7-transcribed RNA from an infectious clone of the same virus to be used as a standard curve. A 5-fold excess of subgenomic transcripts could be detected compared to genomic transcripts starting at 8 hours post infection ( Figure 4A ), recapitulating previously published northern blot data and confirming that this assay can indeed detect subgenomic transcripts.
[0065] Next, this assay was applied in the context of replicons that do not encode structural genes and cannot spread between cells, and the assay also allows for simple quantification of ORF 2 expression coupled to transcription. As a positive control, a similar qRT-PCR assay was designed to detect both genomic and subgenomic levels of alphavirus replicons. Although alphavirus replicons exhibited excessive subgenomic transcription starting 8 hours after transfection, consistent with nLUC expression ( Figure 4B), but the astrovirus replicon (5'-30nt-T2A-3') did not clearly show subgenomic transcription exceeding genomic transcription, and interestingly, nLUC expression was detectable as early as 30 min after transfection ( Figure 4B ).
[0066] These results suggest that: 1) the sequence elements tested are insufficient to mediate subgenomic RNA transcription, and 2) HAstV utilizes an alternative ORF 2 expression mechanism that allows ORF 2 to be translated early independently of subgenomic RNA transcription. Similar observations have been made for caliciviruses that also utilize subgenomic messages to translate their structural genes. Early expression of structural genes independent of subgenomic transcription has been described in bovine norovirus. This may also indicate an important role for structural gene expression in RNA replication.
[0067] Example 5 - Effect of ORF 1a chimera on ORF 2 gene expression
[0068] Regions of ORF 1a, termed hypervariable regions (HVRs), were examined for differences in genomic and subgenomic transcription. HVRs derived from genotype IV HAstV were associated with higher viral titers in clinical samples and differences in the subgenomic to genomic ratio.
[0069] Using the 5'-30nt-T2A-3' replicon described above as the backbone (genotype VII HVR), the HVR was replaced with the HVR of genotype IV HAstV and transfected into CaCo2 cells and BHK cells. Figure 5 As shown in , while no differences in ORF 2 expression were detected in BHK cells, small but significant differences were detected on CaCo-2 cells, supporting previously published data observed for wt virus on CaCo-2 cells. The difference in results between cell lines suggests a role for HVR in host range. Interestingly, HVR chimeras demonstrated lower toxicity in E. coli, resulting in higher plasmid yields, which may prove useful in downstream applications of astrovirus replicons.
[0070] Example 6 - Mechanism of subgenomic transcription-independent ORF 2 translation
[0071] Given the evolutionary relationship between caliciviruses and astroviruses, we next tested whether astroviruses utilize translation termination reinitiation (TTR) between ORF 1b and ORF 2 that allows subgenomic transcription-independent translation of ORF 2 early in the replication cycle in a similar manner to caliciviruses. To test this hypothesis, bicistronic reporter genes encoding Renilla luciferase and firefly luciferase separated by an 808 bp region of ORF 1b and ORF 2 of HAstV-1 were generated in the first and second ORFs, respectively. Fig. 6A ). A series of mutations were then performed to test the importance of ORF 1b stop codons and ORF 2 start codons, because TTR in Calicivirus has been shown to depend on the position of the upstream ORF stop codon, rather than the downstream ORF start codon. As a negative control, a stop codon (3' stop) was inserted at the end of ORF 1b immediately before the ORF 2 start codon. After transfection of BHK cells with 100ng of each plasmid, a dual luciferase assay was performed to first measure firefly activity, then quench and detect Renilla activity ( Figure 6B ). The downstream ORF (firefly) expression was then normalized to the upstream ORF (Renilla) expression relative to the negative control (3' termination).
[0072] The WT ORF 1b / ORF 2 sequence resulted in a 12-fold increase in downstream ORF expression relative to a 3' termination negative control. Although the type of ORF1b stop codon did not appear to be critical for downstream ORF expression, changing the position by replacing the stop codon with TGG, encoding tryptophan, thereby causing the ORF 1b reading frame to extend an additional 34 codons before termination appeared to eliminate downstream ORF expression. Finally, replacing the start codon of ORF 2 with ACG did not appear to affect downstream ORF 2 expression. These findings are consistent with TTR in Calicivirus.
[0073] The mechanism of TTR in caliciviruses has been shown to depend on the binding of complementary sequences in the host 18s ribosomal RNA to upstream sequences in the calicivirus genome, known as translation upstream ribosome binding sites (TURBS), allowing disengaged ribosomes to reinitiate translation of downstream ORFs. To identify the potential location of such a sequence in astrovirus ORF 1b, we next used a bicistronic reporter system ( Fig. 7A ). In addition, mutations were generated within a TURBS-like sequence located in the del3 mutant to see if the sequence was important for downstream ORF expression. The results showed that while the TURBS-like sequence did not appear to significantly affect downstream ORF expression, a 200 bp sequence located within the del3 mutant ( Figure 7B). Interestingly, this 200 bp sequence is expected to form Figure 3C The triple hairpin structure depicted in .
[0074] Equivalent
[0075] The foregoing written description is considered sufficient to enable one skilled in the art to practice the embodiments. The foregoing description and examples detail certain embodiments and describe the best mode contemplated by the inventor. However, it should be understood that no matter how detailed the foregoing may appear in text, the embodiments may be practiced in many ways and should be interpreted in accordance with the appended claims and any equivalents thereof.
[0076] As used herein, the terms refer to values, including, for example, integers, fractions, and percentages, whether or not explicitly stated. The terms generally refer to a range of values (e.g., + / - 5-10% of the range listed) that one of ordinary skill in the art would consider equivalent to the listed value (e.g., having the same function or result). When terms such as at least and etc. precede a list of values or ranges, the terms modify all values or ranges provided in the list. In some cases, the terms may include values rounded to the nearest valid figure.
[0077] Sequence Listing
[0078] The following sequence listing provides a list of sequences disclosed herein. It should be understood that if a DNA sequence (including Ts) is referenced relative to an RNA, then the Ts should be replaced by Us (with or without modification depending on the context), and vice versa.
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101] Sequence Listing <110> Infectious Disease Research Institute <120> Astrovirus replicon methods and compositions <130> 48.PCT <150> 62859683 <151> 2019-06-10 <160> 8 <170> PatentIn Version 3.5 <210> 1 <211> 5278 <212> DNA <213> Human astrovirus <400> 1 ccaagagggg ggtggtgatt ggcctttggc ttatcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaagat ttcaatttg gagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg taggtacta 360 cccaatagag cacttaaatc tcatgtcatc tttgaactg atacacaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaat 540 acgatgaag tggatataa tgggagcagt gcttacattc tatctctga tacctggggg 600 ttatgcgcac agccagacca acaacacat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactacag aaaatcttga ccttagaatc aagcttgcac tagcaacat 720 aaccattagt gataagctag atgctgtgag gcaaatttctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt attttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttatctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagcctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccaattaata gacccatctt tgatgataag 3000 aaacccagggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgactttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tcagagt actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcacacc tgcttatcct aaaatgaatt attttgacac tgagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacactcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctggtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcaacaaca 3840 atggataaca acatggttaa cttttggtta caggcttttg agtttgctta tttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acaacacctt cggtgcccga tgattatgag gagagagtga tcactatgta tagagacatc 4020 tttggcatgt gggttaagcc tgggaaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg agggaggac caaagaagtg tgatggctag 4380 ccctaggatg gtcttcacac tcgaagattt cgttggggac tggcgacaga cagccggcta 4440 caacctggac caagtccttg aacagggagg tgtgtccagt ttgtttcaga atctcggggt 4500 gtccgtaact ccgatccaaa ggattgtcct gagcggtgaa aatgggctga agatcgacat 4560 ccatgtcatc atcccgtatg aaggtctgag cggcgaccaa atgggccaga tcgaaaaaat 4620 ttttaaggtg gtgtaccctg tggatgatca tcactttaag gtgatcctgc actatggcac 4680 actggtaatc gacggggtta cgccgaacat gatcgactat ttcggacggc cgtatgaagg 4740 catcgccgtg ttcgacggca aaaagatcac tgtaacaggg accctgtgga acggcaacaa 4800 aattatcgac gagcgcctga tcaaccccga cggctccctg ctgttccgag taaccatcaa 4860 cggagtgacc ggctggcggc tgtgcgaacg cattctggcg taatagacgc gtgaacgagg 4920 gtacagcttc cttcttttct gtctctgttt agattatttt aatcaccatt taaaattgat 4980 ttaatcagaa gcaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaggg 5040 tcggcatggc atctccacct cctcgcggtc cgacctgggc atccgaagga ggacgcacgt 5100 ccactcggat ggctaaggga gcctgcattc gcagaagcca cccgcgctgc taacaaagcc 5160 cgaaaggaag ctgagttggc tgctgccacc gctgagcaat aactagcata accccttggg 5220 gcctctaaac gggtcttgag gggttttttg ctgaaaggag gaactatatg cgctcata 5278 <210> 2 <211> 5278 <212> DNA <213> Human astrovirus <400> 2 ccaagagggg ggtggtgatt ggcctttggc ttatcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaaagat ttcaattttg gaagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg tagggatcta 360 cccaatagag cacttaaatc tcatgtcatc tttgaaactg atacacaaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcaacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaaat 540 acagatgaag tggataataa tgggagcagt gcttacattc ttatctctga tacctgggggg 600 tttgcgcac agccagacca acaacaccat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactaacag aaaatcttga ccttagaatc aagcttgcac tagcaaacat 720 aaccattagt gataagctag atgctgtgag gcaaattctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt atttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttatctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagcctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccaattaata gacccatctt tgatgataag 3000 aaacccaggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgacttttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tctagaggat actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcaacacc tgcttatcct aaaatgaatt attttgacac tgaagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacactcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctgtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcacaaca 3840 atggataaca acatgttaa cttttggtta caggctttg agttttgctta ttttaatgga 3900 ccagacagag accttggaa gacctatgac actgtagtttt atggagatga caggctttct 3960 acacacctt cggtgcccga tgattgag gagagagtga tcactgta tagagacatc 4020 ttggcatgt gggttaagcc tgggaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg aggggaggac caaagaagtg tgacggctag 4380 ccctaggatg gtcttcacac tcgaagattt cgttggggac tggcgacaga cagccggcta 4440 caacctggac caagtccttg aacagggagg tgtgtccagt ttgtttcaga atctcggggt 4500 gtccgtaact ccgatccaaa ggattgtcct gagcggtgaa aatgggctga agatcgacat 4560 ccatgtcatc atcccgtatg aaggtctgag cggcgaccaa atgggccaga tcgaaaaaat 4620 ttttaaggtg gtgtaccctg tggatgatca tcactttaag gtgatcctgc actatggcac 4680 actggtaatc gacggggtta cgccgaacat gatcgactat ttcggacggc cgtatgaagg 4740 catcgccgtg ttcgacggca aaaagatcac tgtaacaggg accctgtgga acggcaacaa 4800 aattatcgac gagcgcctga tcaaccccga cggctccctg ctgttccgag taaccatcaa 4860 cggagtgacc ggctggcggc tgtgcgaacg cattctggcg tatagacgc gtgaacgagg 4920 gtacagcttc cttcttttct gtctctgttt agattatttt aatcaccatt taaattgat 4980 ttaatcagaa gcaaaaaaaa aaaaaaaaa aaaaaaaaa aaaaaaaaaa aaaaaaaggg 5040 tcggcatggc atctccacct cctcgcggtc cgacctgggc atccgaagga ggacgcacgt 5100 ccactcggat ggctaaggga gcctgcattc gcagaagcca cccgcgctgc taacaaagcc 5160 cgaaaggaag ctgagttggc tgctgccacc gctgagcaat aactagcata accccttggg 5220 gcctaaac gggtcttgag gggttttttg ctgaaaggag gaactatatg cgctcata 5278 <210> 3 <211> 5337 <212> DNA <213> Human astrovirus (Human astrovirus) <400> 3 ccaagagggg ggtggtgatt ggcctttggc tttcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaagat ttcaatttg gagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg taggtacta 360 cccaatagag cacttaaatc tcatgtcatc tttgaactg atacacaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaat 540 acgatgaag tggatataa tgggagcagt gcttacattc tatctctga tacctggggg 600 ttatgcgcac agccagacca acaacacat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactacag aaaatcttga ccttagaatc aagcttgcac tagcaacat 720 aaccattagt gataagctag atgctgtgag gcaaatttctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt attttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttatctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagcctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccaattaata gacccatctt tgatgataag 3000 aaacccagggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgactttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tcagagt actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcacacc tgcttatcct aaaatgaatt attttgacac tgagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacactcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctggtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcaacaaca 3840 atggataaca acatggttaa cttttggtta caggcttttg agtttgctta tttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acaacacctt cggtgcccga tgattatgag gagagagtga tcactatgta tagagacatc 4020 tttggcatgt gggttaagcc tgggaaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg agggaggac caaagaagtg tgatggctag 4380 ccctaggatg gtcttcacac tcgaagattt cgttggggac tggcgacaga cagccggcta 4440 caacctggac caagtccttg aacagggagg tgtgtccagt ttgtttcaga atctcggggt 4500 gtccgtaact ccgatccaaa ggattgtcct gagcggtgaa aatgggctga agatcgacat 4560 ccatgtcatc atcccgtatg aaggtctgag cggcgaccaa atgggccaga tcgaaaaaat 4620 ttttaaggtg gtgtaccctg tggatgatca tcactttaag gtgatcctgc actatggcac 4680 actggtaatc gacggggtta cgccgaacat gatcgactat ttcggacggc cgtatgaagg 4740 catcgccgtg ttcgacggca aaaagatcac tgtaacaggg accctgtgga acggcaacaa 4800 aattatcgac gagcgcctga tcaaccccga cggctccctg ctgttccgag taaccatcaa 4860 cggagtgacc ggctggcggc tgtgcgaacg cattctggcg taatagacgc gtgcaaagca 4920 gcaggggaaa tcaatccctg cacatctgga agccgcggcc acgccgagta ggaacgaggg 4980 tacagcttcc ttcttttctg tctctgttta gattatttta atcaccattt aaaattgatt 5040 taatcagaag caaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaagggt 5100 cggcatggca tctccacctc ctcgcggtcc gacctgggca tccgaaggag gacgcacgtc 5160 cactcggatg gctaagggag cctgcattcg cagaagccac ccgcgctgct aacaaagccc 5220 gaaaggaagc tgagttggct gctgccaccg ctgagcaata actagcataa ccccttgggg 5280 cctctaaacg ggtcttgagg ggttttttgc tgaaaggagg aactatatgc gctcata 5337 <210> 4 <211> 5337 <212> DNA <213> Human astrovirus <400> 4 ccaagagggg ggtggtgatt ggcctttggc ttatcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaaagat ttcaattttg gaagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg tagggatcta 360 cccaatagag cacttaaatc tcatgtcatc tttgaaactg atacacaaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcaacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaaat 540 acagatgaag tggataataa tgggagcagt gcttacattc ttatctctga tacctgggggg 600 tttgcgcac agccagacca acaacaccat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactaacag aaaatcttga ccttagaatc aagcttgcac tagcaaacat 720 aaccattagt gataagctag atgctgtgag gcaaattctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt atttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttattctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagcctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccaattaata gacccatctt tgatgataag 3000 aaacccaggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgacttttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tctagaggat actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcaacacc tgcttatcct aaaatgaatt attttgacac tgaagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacactcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctgtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcacaaca 3840 atggataaca acatgttaa cttttggtta caggctttg agtttgctta ttttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acacacctt cggtgcccga tgattgag gagagagtga tcactgta tagagacatc 4020 tttggcatgt gggttaagcc tgggaaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg aggggaggac caaagaagtg tgacggctag 4380 ccctaggatg gtcttcacac tcgaagattt cgttggggac tggcgacaga cagccggcta 4440 caacctggac caagtccttg aacagggagg tgtgtccagt ttgtttcaga atctcggggt 4500 gtccgtaact ccgatccaaa ggattgtcct gagcggtgaa aatgggctga agatcgacat 4560 ccatgtcatc atcccgtatg aaggtctgag cggcgaccaa atgggccaga tcgaaaaaat 4620 ttttaaggtg gtgtaccctg tggatgatca tcactttaag gtgatcctgc actatggcac 4680 actggtaatc gacggggtta cgccgaacat gatcgactat ttcggacggc cgtatgaagg 4740 catcgccgtg ttcgacggca aaaagatcac tgtaacaggg accctgtgga acggcaacaa 4800 aattatcgac gagcgcctga tcaaccccga cggctccctg ctgttccgag taaccatcaa 4860 cggagtgacc ggctggcggc tgtgcgaacg cattctggcg taatagacgc gtgcaaagca 4920 gcaggggaaa tcaatccctg cacatctgga agccgcggcc acgccgagta ggaacgaggg 4980 tacagcttcc ttcttttctg tctctgttta gattatttta atcaccattt aaaattgatt 5040 taatcagaag caaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaagggt 5100 cggcatggca tctccacctc ctcgcggtcc gacctgggca tccgaaggag gacgcacgtc 5160 cactcggatg gctaagggag cctgcattcg cagaagccac ccgcgctgct aacaaagccc 5220 gaaaggaagc tgagttggct gctgccaccg ctgagcaata actagcataa ccccttgggg 5280 cctctaaacg ggtcttgagg ggttttttgc tgaaaggagg aactatatgc gctcata 5337 <210> 5 <211> 5358 <212> DNA <213> Human astrovirus <400> 5 ccaagagggg ggtggtgat ggcttttggc ttatcagtgt atagataca tttctctgac 60 cgtttaccac acaattaca acaatggc atacggtgag ccatactata gctctaaacc 120 tgacaagat ttcaatttg gagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg taggtacta 360 cccaatagag cacttaaatc tcatgtcatc tttgaactg atacacaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaat 540 acgatgaag tggatataa tgggagcagt gcttacattc tatctctga tacctggggg 600 ttatgcgcac agccagacca acaacacat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactacag aaaatcttga ccttagaatc aagcttgcac tagcaacat 720 aaccattagt gataagctag atgctgtgag gcaaattctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt atttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gttctttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttatctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagccctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccattata gacccatctt tgatgataag 3000 aaacccagggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgactttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tcagagt actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcacacc tgcttatcct aaaatgaatt attttgacac tgagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacacttcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaaattagg tggaatttca tcaataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aaacctcc ttaatcgcca tgtacttcta 3780 ccatctggtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcaacaaca 3840 atggataaca acatggttaa cttttggtta caggcttttg agtttgctta ttttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acaacacctt cggtgcccga tgattatgag gagagagtga tcactatgta tagagacatc 4020 tttggcatgt gggttaagcc tgggaaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg aggggaggac caaagaagtg tgatggctag 4380 caagtccaac aagcaagtaa ctcctaggat ggtcttcaca ctcgaagatt tcgttgggga 4440 ctggcgacag acagccggct acaacctgga ccaagtcctt gaacagggag gtgtgtccag 4500 tttgtttcag aatctcgggg tgtccgtaac tccgatccaa aggattgtcc tgagcggtga 4560 aaatgggctg aagatcgaca tccatgtcat catcccgtat gaaggtctga gcggcgacca 4620 aatgggccag atcgaaaaaa tttttaaggt ggtgtaccct gtggatgatc atcactttaa 4680 ggtgatcctg cactatggca cactggtaat cgacggggtt acgccgaaca tgatcgacta 4740 tttcggacgg ccgtatgaag gcatcgccgt gttcgacggc aaaaagatca ctgtaacagg 4800 gaccctgtgg aacggcaaca aaattatcga cgagcgcctg atcaaccccg acggctccct 4860 gctgttccga gtaaccatca acggagtgac cggctggcgg ctgtgcgaac gcattctggc 4920 gtaatagacg cgtgcaaagc agcaggggaa atcaatccct gcacatctgg aagccgcggc 4980 cacgccgagt aggaacgagg gtacagcttc cttcttttct gtctctgttt agattatttt 5040 aatcaccatt taaaattgat ttaatcagaa gcaaaaaaaa aaaaaaaaaa aaaaaaaaaa 5100 aaaaaaaaaa aaaaaaaggg tcggcatggc atctccacct cctcgcggtc cgacctgggc 5160 atccgaagga ggacgcacgt ccactcggat ggctaaggga gcctgcattc gcagaagcca 5220 cccgcgctgc taacaaagcc cgaaaggaag ctgagttggc tgctgccacc gctgagcaat 5280 aactagcata accccttggg gcctctaaac gggtcttgag gggttttttg ctgaaaggag 5340 gaactatatg cgctcata 5358 <210> 6 <211> 5358 <212> DNA <213> Human astrovirus <400> 6 ccaagagggg ggtggtgatt ggcctttggc ttatcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaaagat ttcaattttg gaagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg tagggatcta 360 cccaatagag cactaatc tcatgtcatc tttgaaactg atacacaaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcaacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaaat 540 acagatgaag tggataataa tgggagcagt gcttacattc ttatctctga tacctgggggg 600 tttgcgcac agccagacca acaacaccat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactaacag aaaatcttga cttagaatc aagcttgcac tagcaaacat 720 aaccattagt gataagctag atgctgtgag gcaaattctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt atttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttattctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gacaaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaa aaaactacaa agggccccag aagaccaagg ggcccaaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagcctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccaattaata gacccatctt tgatgataag 3000 aaacccaggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgacttttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tcagagt actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcacacc tgcttatcct aaaatgaatt attttgacac tgagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacacttcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctgtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcacaaca 3840 atggataaca acatgttaa cttttggtta caggctttg agtttgctta ttttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acaacacctt cggtgcccga tgattatgag gagagagtga tcactatgta tagagacatc 4020 tttggcatgt gggttaagcc tgggaaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc caacttctcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg agggaggac caaagaagtg tgacggctag 4380 caagtccaac aagcaagtaa ctcctaggat ggtcttcaca ctcgaagatt tcgttgggga 4440 ctggcgacag acagccggct acaacctgga ccaagtcctt gaacagggag gtgtgtccag 4500 tttgtttcag aatctcgggg tgtccgtaac tccgatccaa aggattgtcc tgagcggtga 4560 aaatgggctg aagatcgaca tccatgtcat catcccgtat gaaggtctga gcggcgacca 4620 aatgggccag atcgaaaaaa tttttaaggt ggtgtaccct gtggatgatc atcactttaa 4680 ggtgatcctg cactatggca cactggtaat cgacggggtt acgccgaaca tgatcgacta 4740 tttcggacgg ccgtatgaag gcatcgccgt gttcgacggc aaaaagatca ctgtaacagg 4800 gaccctgtgg aacggcaaca aaattatcga cgagcgcctg atcaaccccg acggctccct 4860 gctgttccga gtaaccatca acggagtgac cggctggcgg ctgtgcgaac gcattctggc 4920 gtaatagacg cgtgcaaagc agcaggggaa atcaatccct gcacatctgg aagccgcggc 4980 cacgccgagt aggaacgagg gtacagcttc cttcttttct gtctctgttt agattatttt 5040 aatcaccatt taaaattgat ttaatcagaa gcaaaaaaaa aaaaaaaaaa aaaaaaaaaa 5100 aaaaaaaaaa aaaaaaaggg tcggcatggc atctccacct cctcgcggtc cgacctgggc 5160 atccgaagga ggacgcacgt ccactcggat ggctaaggga gcctgcattc gcagaagcca 5220 cccgcgctgc taacaaagcc cgaaaggaag ctgagttggc tgctgccacc gctgagcaat 5280 aactagcata accccttggg gcctctaaac gggtcttgag gggttttttg ctgaaaggag 5340 gaactatatg cgctcata 5358 <210> 7 <211> 5412 <212> DNA <213> Human astrovirus (Human astrovirus) <400> 7 ccaagagggg ggtggtgatt ggcctttggc tttcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaaagat ttcaattttg gaagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg tagggatcta 360 cccaatagag cactaatc tcatgtcatc tttgaaactg atacacaaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcaacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaaat 540 acagatgaag tggataataa tgggagcagt gcttacattc ttatctctga tacctgggggg 600 tttgcgcac agccagacca acaacaccat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactaacag aaaatcttga cttagaatc aagcttgcac tagcaaacat 720 aaccattagt gataagctag atgctgtgag gcaaattctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt atttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agctatggtg catggcaaca ctctttcata tgcagttcgc acccaggacg ggatgtcggg 1740 tgcaccagtc tgtgacaaat atggtcgggt gttagcagtc catcaaacaa acactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaaag ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg gctaaaagct caactgaact ctgccactga 1920 gaacgcaacg actgtagtta cacaacaacc tagtgctgca ctagaacaga aaagtgtcag 1980 cgatagtgat gtagttgacc ttgtcagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 tgatgaaatc aatggaatac ttgcaccatt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcaggc gtaaccttag aaaaggtgtg aaacttctta ccgaggaaga 2160 gtatcgagaa ctcttagaga aaggtcttga tcgtgagaca ttccttgatc tcatagaccg 2220 cattattggt gagaggtctg gctaccctga ctatgatgat gaagattact atgatgaaga 2280 tgatgatggc tggggaatgg ttggtgatga tgtagaattt gattactg aagtaattaa 2340 ctttgaccaa gcaaaaccaa ttcctgcccc gagaacaacc aagcaaaaaa tttgccccga 2400 accagaagtc gaatcacaac cacttgattt gtcccaaaag aaagaaaaac aatcagaata 2460 tgaacaacaa gtggtgaagt ctaccaagcc tcaacaatta gaacatgaac aacaagtggt 2520 gaagcctatc aagcctcaga agagtgagcc tcaaccatac tcacaaactt acggcaaggc 2580 accaatctgg gaatcttacg attttgactg ggatgaggat gatgccaagt ttatctgcc 2640 agcgccacac cggttgacta aggcagatga aatagtcctt ggatccaaaa tcgtcaagct 2700 tagaacgatt attgaaacag ccataaagac tcagaattat agtgcattac ctgaagcagt 2760 atttgagctc gandaagcag cttatgaagc aggtttggaa ggttttctcc aaagggttaa 2820 atcgaaaaac aaggccccaaaaactacaaagggccccag aagaccaagg ggcccaaac 2880 taccactcat tagatgcatg gaaattgttg ctagagccctc cgcgggagcg aaggtgcgtg 2940 cctgcgaatt ttccactatt aggccattta ccattata gacccatctt tgatgataag 3000 aaacccagggg acgatctcct tggcctactt ccagaaccaa cctggcatgc tttcgaggaa 3060 tacggaccaa ccacatgggg cccacaagct tttatcaaat cttttgataa atttttttat 3120 gcagaaccaa ttgactttt ctcagaatat ccacagttgt gtgctttcgc tgattgggca 3180 acttatcgcg agtttcggta tcagagt actagagtga tacacataac tgcaactgag 3240 aaaaacactg attcacacc tgcttatcct aaaatgaatt attttgacac tgagaaaat 3300 tacctggaag cacatgggtg ggcaccatat attagagaat tcactagggt ctacaaagga 3360 vakaaacctg aagtactttg gtacctattt cttagaaag agatcattaa ggaggaaaaa 3420 attaggaatt ctgatatccg gcagatagtg tgtgccgacc ccatttacac caggatagg 3480 gcgtgcttag aagcgcatca gatgcctta atgaacagc ataccgacac ctcagttggt 3540 caatgtgggt ggtcaccaat ggaggcggc tttaaaaaaa ccatgcagcg cctggtaaat 3600 aaagggaata aacacttcat tgagttcgac tggacccgct atgatggaac tataccacca 3660 gcactcttta aacacatcaa agaattagg tggaatttca tcataaaga ccaacgtgaa 3720 aagtacagac atgtacatga atggtatgtt aacaacctcc ttaatcgcca tgtacttcta 3780 ccatctgtg aagtcacctt gcagacgcga ggtaatccat ctggtcagtt ttcacaaca 3840 atggataaca acatgttaa cttttggtta caggctttg agtttgctta ttttaatgga 3900 ccagacagag acctttggaa gacctatgac actgtagttt atggagatga caggctttct 3960 acacacctt cggtgcccga tgattgag gagagagtga tcactgta tagagacatc 4020 ttggcatgt gggttaagcc tgggaggtt atctgtagag acagcatagt tggattgtcc 4080 ttttgtggct tcactgttaa tgaaaacctt gagcctgtgc CACTCTcc tgaaaagtta 4140 atggcatcac tgttaaaacc ttacaaata ttacctgatc ttgaatcact ccatgggaaa 4200 ctcctatgct atcagttgct tgctgcgttc atggcagagg accacccctt taaggtgtat 4260 gtggagcact gcctctcgcg gactgcaaag cagcttcgtg actctggcct tccagccaga 4320 ctcacagaag agcaactcca tcgcatttgg aggggaggac caaagaagtg tgatggctag 4380 caagtccaac aagcaagtaa ctgaaggccg gggcagtctg ctgacgtgcg gcgacgtaga 4440 agaaaatcct ggtcccccta ggatggtctt cacactcgaa gatttcgttg gggactggcg 4500 acagacagcc ggctacaacc tggaccaagt ccttgaacag ggaggtgtgt ccagtttgtt 4560 tcagaatctc ggggtgtccg taactccgat ccaaaggatt gtcctgagcg gtgaaaatgg 4620 gctgaagatc gacatccatg tcatcatccc gtatgaaggt ctgagcggcg accaaatggg 4680 ccagatcgaa aaaattttta aggtggtgta ccctgtggat gatcatcact ttaaggtgat 4740 cctgcactat ggcacactgg taatcgacgg ggttacgccg aacatgatcg actatttcgg 4800 acggccgtat gaaggcatcg ccgtgttcga cggcaaaaag atcactgtaa cagggaccct 4860 gtggaacggc aacaaaatta tcgacgagcg cctgatcaac cccgacggct ccctgctgtt 4920 ccgagtaacc atcaacggag tgaccggctg gcggctgtgc gaacgcattc tggcgtaata 4980 gacgcgtgca aagcagcagg ggaaatcaat ccctgcacat ctggaagccg cggccacgcc 5040 gagtaggaac gagggtacag cttccttctt ttctgtctct gtttagatta ttttaatcac 5100 catttaaaat tgatttaatc agaagcaaaa aaaaaaaaaa aaaaaaaaa aaaaaaaaaa 5160 aaaaaaaaa agggtcggca tggcatctcc acctcctcgc ggtccgacct gggcatccga 5220 aggaggacgc acgtccactc ggatggctaa gggagcctgc attcgcagaa gccacccgcg 5280 ctgctaacaa agcccgaaag gaagctgagt tggctgctgc caccgctgag caataactag 5340 cataacccct tggggcctct aaacgggtct tgaggggttt tttgctgaaa ggaggaacta 5400 tatgcgctca is 5412 <210> 8 <211> 5388 <212> DNA <213> Human astrovirus (Human astrovirus) <400> 8 ccaagagggg ggtggtgatt ggcctttggc tttcagtgt atagataaca tttctctgac 60 cgtttaccac acaattaaca acaatatggc atacggtgag ccatactata gctctaaacc 120 tgacaagat ttcaatttg gagcacaat ggcacgtagg cagatgacac ctactatggt 180 aacaaagctt cccaatttg ttaggaattc tccacaagct tatgattgga tcgtaagagg 240 tctgatcttt cccaccattg gtaaaactta tttccaacga gttgttgtga ttactggtgg 300 gcttgaggat ggaacatatg gctcattcgc atttgacggt aaagagtggg taggtacta 360 cccaatagag cacttaaatc tcatgtcatc tttgaactg atacacaag ccaacgctct 420 tcaggagaga ctgcgtctct cccaagaga gaaagccacc ctcgctctgg atgtgcaatt 480 ccttcacat gaaaacgtgc gattgaagga gatgatccca aagccagagc cacggaaat 540 acgatgaag tggatataa tgggagcagt gcttacattc tatctctga tacctggggg 600 ttatgcgcac agccagacca acaacacat atttactgac atgatagctg cctgcaagta 660 ctcaactgag acactacag aaaatcttga ccttagaatc aagcttgcac tagcaacat 720 aaccattagt gataagctag atgctgtgag gcaaatttctt aactttgcct ttgtgcccag 780 agcccattgg ttgagaactg tgttctatta tatccattac tatgaaatgt ggaatatttt 840 tatgtttgtt cttgctattg gcactgtcat gaggagcgcc cgccctggta cagacttggt 900 tacacttgca acatcccact tgtctggttt taggatggct gtcctaccca caattccatt 960 tcacaccact atgactttgt gggttatgaa cacacttatg gtttgttatt attttgacaa 1020 cttgctagca ataacattgg caatcttagc accaattctt ggcattatct tcttgtgctt 1080 catggaagac tccaactatg tgagccagat acgtggcctt attgctacag cagtattaat 1140 tgctggtggg catgcatgtt tgacactcac aggcacgacc acgtcattgt ttgttgtcat 1200 actaacctgt aggttcatac gtatggcaac tgttttcatt ggcaccaggt tcgagatccg 1260 tgacgctaat ggaaaggttg tggccactgt accaactagg attaaaaatg ttgcatttga 1320 cttttttcag aagctgaagc agtcaggggt gcgagttgga gtcaacgaat tcgttgtcat 1380 aaaaccaggt gcattatgtg ttatagacac ccctgaagga aaagggacag gtttcttttc 1440 tggcaatgac atagtaacag cagcacatgt tgttggcaat aatacttttg tgaatgtgtg 1500 ctatgagggt ttgatgtatg aagcgaaggt gcggtacatg cccgaaaagg atatagcatt 1560 cttaacttgt cctggtgacc tgcatccaac agcaagatta aaattatcaa agaacccaga 1620 ttatagttgt gtcacagtta tggcttatgt gaatgaggat cttgtggttt caaccgcagc 1680 agccatggta catggcaaca ctctctcata tgcagttcgc actcaagacg gaatgtcagg 1740 tgcaccagtt tgtgacaaat atggtcgagt gttagcagtc catcagacta atactgggta 1800 cactggaggt gctgtcataa tagacccagc agacttccat ccagtgaagg ccccatctca 1860 ggtggaattg ctcaaagagg aaatagagcg attaaaagcc caattaaatt ccaccgctga 1920 gaatccagcg actgttgtta cacaacaacc tattgctaca ctagagcaga aaagtgtcag 1980 cgatagcgat gtgattgacc ttgttagaac tgcaatggaa cgtgagatga aggtgctgcg 2040 cgatgaaatc aatgggatac ttgcaccgtt cctacaaaaa aagaaaggta agaccaagca 2100 tggtaggggt agagtcagac gaaaccttag gaaaggtgtg aaacttctca ctgaggaaga 2160 atatcgagag ctcttagaga aaggtctgga tcgtgagaca ttcctagatc tcatagaccg 2220 tattattggt gagaggtctg gctaccctga ctatgatgat gaggattatt atgatgaaga 2280 tgatgatgga tggggtatgg ttggtgatga tgtagaattt gattataccg aagtaatcaa 2340 ttttgaccaa gcaaaccaa ctcctgcccc gagaacaagt aagccacaac aagccacac 2400 ttctcaaaa ccccgccccg agctagaagc tgaagcacaa ccgctgatt tgtctcagaa 2460 gaaagaaaaaaccagaaac aggxaaaagtggcgaaacc cctaccaaaaagggaaa 2520 tgaacctcaa ccatattcac aaacttatgg CAggcacca atctgggaat cctatgactt 2580 tgattgggat gaggatgacg ccaagttcat tctccagcg cctcaccggt tgactaggc 2640 agatgaaata gtccttggat ccaaatcgt caagcttaga acgattattg aacagccat 2700 aaagactcag aattatagtg cattacctga agcagtattt gagctcgaca aagcagctta 2760 tgaagcaggt tggaaggtt ttctccaag ggttaaatcg aaaaacaag ccccaaaaaa 2820 ctacaaaggg cccagaga ccaaggggcc haaactacc actcattaga tgcatggaaa 2880 ttgttgctag agcctccgcg ggagcgaagg tgcgtgcctg cgaatttcc actattaggc 2940 catttaccaa ttaatagacc catctgat gataagaac ccaggacga tctccttggc 3000 ctacttccag aaccaacctg gcatgctttc gaggaatacg gaccaccac atggggccca 3060 caagcttta tcaatcttt tgataaattt ttttatgcag aaccaattga ctttttctca 3120 gatatccac agttgtgtgc tttcgctgat tgggcaactt atcgcgagtt tcggtatcta 3180 gaggatacta gagtgataca cataactgca actgagaaaa acactgattc aacacctgct 3240 tatcctaaaa tgaattattt tgacactgaa gaaaattacc tggagcaca tggtgggca 3300 ccatatatta gagaattcac taggtctac aaggagaca aacctgaagt actttggtac 3360 ctatttctta agaagagat chattaggag gaaaaatta ggaattctga tatccggcag 3420 atagtgtgtg ccgacccat ttacaccagg atagggggt gcttagaagc gcatcagaat 3480 gccttaatga aacagcatac cgacaccctca gttggtcaat gtgggtggtc accaatggaa 3540 ggcggcttta aaaaaaccat gcagcgcctg gtaataaag ggataaaca cttcattgag 3600 ttcgactgga cccgctatga tggaactata ccaccaccac tctttaaaca catcaagaa 3660 attaggtgga atttcatca taaagaccaa cgtgaaagt acagacatgt acatgaatgg 3720 tatgttaaca acctccttaa tcgccatgta cttctaccat ctggtgaagt caccttgcag 3780 acgcgaggta atccatctgg tcagttttca acaacaatgg ataacaacat ggttaacttt 3840 tggttacagg cttttgagtt tgctttttt aatggaccag acagagacct ttggaagacc 3900 tatgacactg tagtttatgg agatgacagg ctttctacaa caccttcggt gcccgatgat 3960 tatgaggaga gagtgatcac tatgtataga gacatctttg gcatgtgggt taagcctggg 4020 aaggttatct gtagagacag catagttgga ttgtccttt gtggcttcac tgttaatgaa 4080 aaccttgagc ctgtgccaac ttctcctgaa aagttaatgg catcactgtt aaaaccttac 4140 aaaatattac ctgatcttga atcactccat gggaaactcc tatgctatca gttgcttgct 4200 gcgttcatgg cagaggacca cccctttaag gtgtatgtgg agcactgcct ctcgcggact 4260 gcaaagcagc ttcgtgactc tggccttcca gccagactca cagaagagca actccatcgc 4320 atttggaggg gaggaccaaa gaagtgtgat ggctagcaag tccaacaagc aagtaactga 4380 aggccggggc agtctgctga cgtgcggcga cgtagaagaa aatcctggtc cccctaggat 4440 ggtcttcaca ctcgaagatt tcgttgggga ctggcgacag acagccggct acaacctgga 4500 ccaagtcctt gaacagggag gtgtgtccag tttgtttcag aatctcgggg tgtccgtaac 4560 tccgatccaa aggattgtcc tgagcggtga aaatgggctg aagatcgaca tccatgtcat 4620 catcccgtat gaaggtctga gcggcgacca aatgggccag atcgaaaaaa tttttaaggt 4680 ggtgtaccct gtggatgatc atcactttaa ggtgatcctg cactatggca cactggtaat 4740 cgacggggtt acgccgaaca tgatcgacta tttcggacgg ccgtatgaag gcatcgccgt 4800 gttcgacggc aaaaagatca ctgtaacagg gaccctgtgg aacggcaaca aaattatcga 4860 cgagcgcctg atcaaccccg acggctccct gctgttccga gtaaccatca acggagtgac 4920 cggctggcgg ctgtgcgaac gcattctggc gtaatagacg cgtgcaaagc agcaggggaa 4980 atcaatccct gcacatctgg aagccgcggc cacgccgagt aggaacgagg gtacagcttc 5040 cttcttttct gtctctgttt agattatttt aatcaccatt taaaattgat ttaatcagaa 5100 gcaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaggg tcggcatggc 5160 atctccacct cctcgcggtc cgacctgggc atccgaagga ggacgcacgt ccactcggat 5220 ggctaaggga gcctgcattc gcagaagcca cccgcgctgc taacaaagcc cgaaaggaag 5280 ctgagttggc tgctgccacc gctgagcaat aactagcata accccttggg gcctctaaac 5340 gggtcttgag gggttttttg ctgaaaggag gaactatatg cgctcata 5388
Claims
1. A recombinant replicon nucleic acid comprising: a. A first open reading frame, which is composed of the first 30 nucleotides encoding VP90, a nucleic acid sequence encoding a peptide having ribosome skipping properties, a subgenomic nucleic acid sequence encoding a protein of interest that can be secreted by a cell, and an astrovirus conserved sequence element, and arranged in sequence, and the astrovirus conserved sequence element starts within the first open reading frame and extends beyond the 3' end of the first open reading frame; b. a second open reading frame, wherein the second open reading frame encodes nsP1a and comprises a nucleic acid sequence of a hypervariable region; and c. a third open reading frame, the third open reading frame being a nucleic acid sequence encoding nsP1b and comprising a subgenomic promoter, the subgenomic promoter being positioned so as to initiate transcription of the subgenomic nucleic acid sequence, wherein the recombinant replicon nucleic acid has a HAstV VII human astrovirus genotype, and the hypervariable region has a HAstV IV human astrovirus genotype, wherein the recombinant replicon nucleic acid has a 5' untranslated region and a 3' untranslated region, and has a 7-methylguanylate cap at its 5' end, and The recombinant replicon nucleic acid has the following structure: b.→c.→a.
2. The recombinant replicon nucleic acid of claim 1, wherein the third open reading frame comprises a translation upstream ribosome binding site.
3. The recombinant replicon nucleic acid according to claim 1, wherein the peptide having ribosome skipping properties is a 2A peptide (T2A) from the capsid protein of Thosea asigna virus.
4. The recombinant replicon nucleic acid of any one of claims 1 to 3, wherein the protein of interest is the Mycobacterium tuberculosis antigen ID-93.
5. The recombinant replicon nucleic acid of any one of claims 1-3, wherein the protein of interest is Zika virus NS3 antigen.
6. A nanoparticle comprising the recombinant replicon nucleic acid according to any one of the preceding claims.
7. The nanoparticle according to claim 6, which consists of a nanostructured lipid carrier containing the recombinant replicon nucleic acid.
8. A formulation comprising a plurality of nanoparticles according to any one of claims 6 or 7 in a pharmaceutically acceptable carrier.
9. A composition comprising the recombinant replicon nucleic acid according to any one of claims 1 to 5 in a pharmaceutically acceptable carrier.
10. An isolated cell comprising the recombinant replicon nucleic acid according to any one of claims 1 to 5.
11. Use of the formulation according to claim 8 in the preparation of a medicament for treating a subject to immunize the subject, the treatment comprising administering the formulation to the subject and thereby eliciting an immune response in the subject.
12. The use according to claim 11, wherein the immune response comprises CD4+ T cell activation.
13. A method for secreting a protein of interest from a cell, the method comprising introducing a recombinant replicon nucleic acid according to any one of claims 1 to 5 into the cell under conditions whereby the protein of interest is secreted, wherein the cell is in cell culture, whereby the protein is secreted from the cell.
14. The method of claim 13, further comprising the step of harvesting the protein of interest from the cell culture.
